Australia markets closed

Carisma Therapeutics, Inc. (CARM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.4100+0.0400 (+2.92%)
At close: 04:00PM EDT
1.3700 -0.04 (-2.84%)
After hours: 07:38PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
15,073
14,919
9,834
0
0
Operating expenses
Research development
74,946
74,125
56,618
34,387
23,292
Selling general and administrative
25,396
29,525
9,378
6,407
5,086
Total operating expenses
100,342
103,650
65,996
40,794
28,378
Operating income or loss
-85,269
-88,731
-56,162
-40,794
-28,378
Interest expense
-
-
3,145
-
-
Total other income/expenses net
-
-84
-1,919
-
-
Income before tax
-81,324
-86,879
-61,226
-40,784
-28,349
Income from continuing operations
-81,215
-86,879
-61,226
-40,784
-28,349
Net income
-81,215
-86,879
-61,226
-40,784
-28,349
Net income available to common shareholders
-81,215
-86,879
-61,226
-40,784
-28,349
Basic EPS
-1.21
-2.59
-1.52
-1.01
-0.70
Diluted EPS
-1.21
-2.59
-1.52
-1.01
-0.70
Basic average shares
40,255
33,524
40,255
40,255
40,255
Diluted average shares
40,255
33,524
40,255
40,255
40,255